Bivin & Associates’s CVS Health CVS Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2022
Q2
$962K Sell
10,382
-294
-3% -$28.7K 1.03% 22
2022
Q1
$1.08M Sell
10,676
-1,717
-14% -$180K 0.99% 31
2021
Q4
$1.28M Buy
+12,393
New +$1.15M 1.12% 16

Other funds holding CVS

Bivin & Associates's CVS Position: Q2 2022 in Review

Bivin & Associates reduced its CVS Health (CVS) stake by 2.8% in Q2 2022, selling an estimated $28.7K and leaving 10,382 shares worth $962K. The position accounts for 1.03% of the portfolio, ranked #22.

Bivin & Associates first reported a position in CVS in Q4 2021 and has held it in 3 quarters since. The position peaked at $1.28M in Q4 2021. 2,308 funds tracked by Wall St. Rank hold CVS as of Q2 2022.

  • Bivin & Associates held 10,382 shares of CVS Health worth $962K as of Q2 2022.
  • Bivin & Associates sold 294 CVS Health shares in Q2 2022, an estimated $28.7K.
  • CVS Health made up 1.03% of Bivin & Associates's portfolio in Q2 2022, its #22 holding.
  • Bivin & Associates first reported a position in CVS Health in Q4 2021 and has held it in 3 quarters since.
  • Bivin & Associates's CVS Health position peaked at $1.28M in Q4 2021.
  • 2,308 funds tracked by Wall St. Rank held CVS Health as of Q2 2022.

Based on Bivin & Associates's 13F filing for Q2 2022, filed 11 Aug 2022.